AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Andresen, Bradley T ^b   Shome, Kuntala ^a   Jackson, Edwin K ^a   Romero, Guillermo G ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

cGMP; Hypertension; Phosphorylation of RhoA; S188a RhoA; Vascular biology

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CYCLIC GMP; NITRIC OXIDE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE D;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; CELL CULTURE; GENETICS; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; WISTAR KYOTO RAT;

ANIMALS; CELLS, CULTURED; CLONING, MOLECULAR; CYCLIC GMP; HYPERTENSION, RENAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE D; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 15044355292     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00323.2004     Document Type: Article

References (53)

1. Akishita M, Yamada H, Dzau VJ, and Horiuchi M. Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. Biochem Biophys Res Commun 261: 345-349, 1999.
2. Aktories K and Hall A. Botulinum ADP-ribosyltransferase C3: a new tool to study low molecular weight GTP-binding proteins. Trends Pharmacol Sci 10: 415-418, 1989.
3. Andresen BT, Jackson EK, and Romero GG. Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension 37: 635-639, 2001.
4. Andresen BT, Linnoila JJ, Jackson EK, and Romero GG. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension 41: 781-786, 2003.
5. Andresen BT, Rizzo MA, Shome K, and Romero G. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett 531: 65-68, 2002.
6. 1 receptor-induced phospholipase D activation in vascular smooth muscle cells. J Pharmacol Exp Ther 309: 425-431, 2004.
7. Asano M and Nomura Y. Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats. Hypertens Res 26: 97-106, 2003.
8. 2 receptors. Circ Res 94: 1623-1629, 2004.
9. Carey RM, Howell NL, Jin XH, and Siragy HM. Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 38: 1272-1277, 2001.
10. 2) angiotensin receptor. Acta Physiol Scand 168: 65-71, 2000.
11. Chatziantoniou C, Daniels FH, and Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 259: F372-F382, 1990.
12. 2-receptor-mediated relaxation by NOS pathway. J Pharmacol Exp Ther 311: 394-401, 2004.
13. Ellerbroek SM, Wennerberg K, and Burridge K. Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278: 19023-19031, 2003.
14. Essler M, Staddon JM, Weber PC, and Aepfelbacher M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 164: 6543-6549, 2000.
15. Ferrone RA and Antonaccio MJ. Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225). Eur J Pharmacol 60: 131-137, 1979.
16. Forget MA, Desrosiers RR, Gingras D, and Beliveau R. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J 361: 243-254, 2002.
17. Freeman EJ, Ferrario CM, and Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens 8: 1105-1111, 1995.
18. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, and Mayer B. Potent/and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188, 1995.
19. Grisk O and Rettig R. Renal transplantation studies in genetic hypertension. News Physiol Sci 16: 262-265, 2001.
20. 2 receptor: signaling and transport. J Am Soc Nephrol 10, Suppl 11: S69-S74, 1999.
21. Hansen JL, Servant G, Baranski TJ, Fujita T, Iiri T, and Sheikh SP. Functional reconstitution of the angiotensin II type 2 receptor and Gi activation. Circ Res 87: 753-759, 2000.
22. 2 receptors in the pressure-overloaded aorta after banding. Hypertension 43: 1258-1263, 2004.
23. Hwang TL, Wu CC, and Teng CM. YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea. Br J Pharmacol 128: 577-584, 1999.
24. Jackson EK and Herzer WA. Regional vascular selectivity of angiotensin II. J Pharmacol Exp Ther 297: 736-745, 2001.
25. 2- dependent signaling in rabbit proximal tubular epithelial cells. Hypertension 28: 663-668, 1996.
26. 2 inhibition by alkylbenzoylacrylic acids. Biochem Pharmacol 44: 805-813, 1992.
27. Lang P, Gesbert F, Delespine-Carmagnat M, Stancou R, Pouchelet M, and Bertoglio J. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 15: 510-519, 1996.
28. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
29. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, and Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
30. Madeddu P, Anania V, Varoni MV, Parpaglia PP, Demontis MP, Fattaccio MC, Palomba D, Pollock D, and Glorioso N. Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability. Br J Pharmacol 115: 557-562, 1995.
31. Meacci E, Taira M, Moos M Jr, Smith CJ, Movsesian MA, Degerman E, Belfrage P, and Manganiello V. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc Natl Acad Sci USA 89: 3721-3725, 1992.
32. Miao L, Dai Y, and Zhang J. Mechanism of RhoA/Rho kinase activation in endothelin-1- induced contraction in rabbit basilar artery. Am J Physiol Heart Circ Physiol 283: H983-H989, 2002.
33. Michel JB, Sayah S, Guettier C, Nussberger J, Philippe M, Gonzalez MF, Carelli C, Galen FX, Menard J, and Corvol P. Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin. Circulation 81: 1899-1910, 1990.
34. Murthy KS, Zhou H, Grider JR, and Makhlouf GM. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA. Am J Physiol Gastrointest Liver Physiol 284: G1006-G1016, 2003.
35. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, Parmentier JH, Estes A, and Malik KU. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 36: 604-609, 2000.
36. Palicz A, Foubert TR, Jesaitis AJ, Marodi L, and McPhail LC. Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components. J Biol Chem 276: 3090-3097, 2001.
37. Rizzo MA, Shome K, Vasudevan C, Stolz DB, Sung TC, Frohman MA, Watkins SC, and Romero G. Phospholipase D and its product, phosphatidic acid, mediate agonist- dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J Biol Chem 274: 1131-1139, 1999.
38. Ryu SB, Karlsson BH, Ozgen M, and Palta JP. Inhibition of phospholipase D by lysophosphatidylethanolamine, a lipid- derived senescence retardant. Proc Natl Acad Sci USA 94: 12717-12721, 1997.
39. Sandau KB, Gantner F, and Brune B. Nitric oxide-induced F-actin disassembly is mediated via cGMP, cAMP, and protein kinase A activation in rat mesangial cells. Exp Cell Res 271: 329-336, 2001.
40. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
41. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, and Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104, 2001.
42. Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, Yurugi T, and Nakao K. cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 280: 798-805, 2001.
43. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
44. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, and Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 89: 488-495, 2001.
45. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, and Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
46. Shome K, Rizzo MA, Vasudevan C, Andresen B, and Romero G. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle AlO cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 141: 2200-2208, 2000.
47. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997.
48. 2) angiotensin receptor. Proc Natl Acad Sci USA 96: 6506-6510, 1999.
49. Smolenski A, Burkhardt AM, Eigenthaler M, Butt E, Gambaryan S, Lohmann SM, and Walter U. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn Schmiedebergs Arch Pharmacol 358: 134-139, 1998.
50. Touyz RM, El Mabrouk M, He G, Wu XH, and Schiffrin EL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 84: 505-515, 1999.
51. Touyz RM and Schiffrin EL. ANG II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34: 976-982, 1999.
52. Tsukada S, Keino-Masu K, Masu M, and Fukuda J. Activation of protein kinase A by nitric oxide in cultured dorsal root ganglion neurites of the rat, examined by a fluorescence probe, ARII. Neurosci Lett 318: 17-20, 2002.
53. 1 receptor blockade. Hypertension 40: 516-520, 2002.